Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine in Septic Shock
NCT05725837Phase 2Completed
- Sponsor
- Universidade do Extremo Sul Catarinense
- Start
- Jun 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in septic shock and sepsis comparing Placebo with Paroxetine (2 arms). Primary endpoint: Time to vasopressor discontinuation at 28 days. Started Jun 2023; status: completed.
02
Drugs
paroxetine
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on NCT05725837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05725837.